Methylphenidate Hydrochloride Tablet, Extended Release — FDA Drug Shortage

Current — Lannett Company, Inc.

The FDA lists a drug shortage record for Methylphenidate Hydrochloride Tablet, Extended Release (tablet) from Lannett Company, Inc. with status Current. The shortage was first posted on Jul 26, 2023. Reported reason: Other

Shortage details

Status
Current
Company
Lannett Company, Inc.
Package NDC
62175-313-37
Dosage Form
Tablet
Presentation
Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62175-313-37)
Initial Posting
Jul 26, 2023

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.